[Translation] A multi-center, randomized, blinded evaluation, positive drug-controlled phase IIIb clinical trial evaluating the efficacy and safety of recombinant lysostaphin varnish in the treatment of deep Ⅱo burn wounds complicated with methicillin-resistant Staphylococcus aureus MRSA infection
主要目的:初步评价重组溶葡萄球菌酶涂剂治疗深Ⅱo烧伤创面合并MRSA感染的完全创面闭合时间(天)。
次要目的:评价重组溶葡萄球菌酶涂剂治疗深Ⅱo烧伤创面合并MRSA感染的完全创面闭合发生率、创面愈合率、细菌学疗效、综合疗效和安全性。
[Translation] Main purpose: To preliminarily evaluate the complete wound closure time (days) of recombinant lysostaphin varnish in the treatment of deep Ⅱo burn wounds complicated with MRSA infection.
Secondary objective: To evaluate the incidence of complete wound closure, wound healing rate, bacteriological efficacy, comprehensive efficacy and safety of recombinant lysostaphin varnish in the treatment of deep Ⅱo burn wounds complicated with MRSA infection.